Download FREE Report Sample
Download Free sampleTestosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
Testosterone Hormone Drug Market contains market size and forecasts of Testosterone Hormone Drug in global, including the following market information:
Global Testosterone Hormone Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Testosterone Hormone Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Testosterone Hormone Drug companies in 2021 (%)
The global Testosterone Hormone Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gels Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Testosterone Hormone Drug include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
surveyed the Testosterone Hormone Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Testosterone Hormone Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Testosterone Hormone Drug Market Segment Percentages, by Type, 2021 (%)
Gels
Injections
Patches
Global Testosterone Hormone Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Testosterone Hormone Drug Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Testosterone Hormone Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Testosterone Hormone Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Testosterone Hormone Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Testosterone Hormone Drug revenues share in global market, 2021 (%)
Key companies Testosterone Hormone Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Testosterone Hormone Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
